Status:
WITHDRAWN
Evaluation Study of New Compounds With Potential Use in Schizophrenia
Lead Sponsor:
Central Institute of Mental Health, Mannheim
Collaborating Sponsors:
Max Planck Institute for Metabolism Research
Conditions:
Schizophrenia
Eligibility:
All Genders
18-65 years
Phase:
PHASE1
Brief Summary
Different compounds that might modify the glucose regulation in the central nervous system will be evaluated in healthy volunteers. Several examinations will be performed in order to get a detailed pl...
Eligibility Criteria
Inclusion
- Healthy volunteers
- Informed consent given by the subject
- Both, female and male subjects may participate
- Age between 18 and 65 years
- Negative drug-screening at the time of screening
- In female participants in fertile age, reliable contraception, which means contraception's pearl-index is equal or smaller than 1.
- Non-Smoker
- Body Mass Index between 18 and 40.
Exclusion
- Lack of accountability
- Any current psychiatric disorder through the Structured Clinical Interview for DSM-IV (SCID) at the time of screening
- Any known psychiatric or neurological illness in the participant's history.
- Known family history concerning psychiatric disorders
- Relevant use of cannabis (which is defined on the present state of knowledge as at the most five times lifetime-consumption and no consumption for at least one year)
- Pregnancy or lactation phase in female at the time of screening
- Severe physical (internal) or neurological illness, especially cardiovascular, renal, advanced respiratory, haematological or endocrinological failures or infectious diseases (acute hepatitis A, B or C or HIV) assessed at the time of the screening by the subject's history, clinical examination and laboratory testing, at the discretion of the investigator
- Consumption of any illegal drugs (except cannabis in history, see above)
Key Trial Info
Start Date :
January 31 2025
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2025
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00916201
Start Date
January 31 2025
End Date
January 31 2025
Last Update
March 21 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dep. of Psychiatry and Psychotherapy, Central Institute of Mental Health
Mannheim, Baden-Wurttemberg, Germany, 68159